Investment firm KKR has agreed to buy medical‑device outsourcing company Integer Holdings for about $4.3 billion in cash. The deal terms include a purchase price of $127 per share, representing a 4.8% premium to Integer’s Friday close of $121.21 and roughly 52% above the April 29 price of $83.67, when the company first signaled it was open to a sale.

The transaction, announced Monday, follows earlier reports that KKR was negotiating to take Integer private. The acquisition will allow the Plano, Texas‑based firm to expand its footprint in the medical‑device services sector, while giving Integer shareholders a lucrative exit opportunity.

Integer’s board accepted the offer, citing the premium and the backing of a seasoned private‑equity investor. KKR will pay the full amount in cash, with no stock exchange involved.

As the deal closes, industry observers will watch how the integration unfolds and whether the combined entity can leverage synergies across product development, manufacturing, and global supply chains.